These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 34523989)

  • 21. Hospital laboratory experience with SARS-CoV-2 (COVID-19) molecular assay sample pooling method in New York City.
    Genco IS; Williams K; Pacheco J; Vele O; Duong S; Otero Espinal D
    J Clin Pathol; 2022 Jan; 75(1):65-67. PubMed ID: 33589530
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of SARS-CoV-2 PCR-Based Detection Using Saliva or Nasopharyngeal Swab Specimens in Asymptomatic Populations.
    Fan G; Qin X; Streblow DN; Hoyos CM; Hansel DE
    Microbiol Spectr; 2021 Sep; 9(1):e0006221. PubMed ID: 34431689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of SARS-CoV-2 packaged RNA reference material for nucleic acid testing.
    Lee SS; Kim S; Yoo HM; Lee DH; Bae YK
    Anal Bioanal Chem; 2022 Feb; 414(5):1773-1785. PubMed ID: 34958396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. When False-Positives Arise: Troubleshooting a SARS-Coronavirus-2 (SARS-CoV-2) Detection Assay on a Semi-Automated Platform.
    Hampel KJ; Gerrard DL; Francis D; Armstrong J; Cameron M; Ostafin A; Mahoney B; Malik M; Sidiropoulos N
    J Appl Lab Med; 2024 Jul; 9(4):716-727. PubMed ID: 38507614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 Infection and the COVID-19 Pandemic Emergency: The Importance of Diagnostic Methods.
    Ciotti M; Benedetti F; Zella D; Angeletti S; Ciccozzi M; Bernardini S
    Chemotherapy; 2021; 66(1-2):17-23. PubMed ID: 33744904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid detection of SARS-CoV-2 by pulse-controlled amplification (PCA).
    Zwirglmaier K; Weyh M; Krüger C; Ehmann R; Müller K; Wölfel R; Stoecker K
    J Virol Methods; 2021 Apr; 290():114083. PubMed ID: 33515664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementing Pool-Based Surveillance Testing for SARS-CoV-2 at the Army Public Health Center Laboratory and across the Army Public Health Laboratory Enterprise.
    McGhee LL; Yerramilli SV; Nadolny R; Casal C; Kearney BM; Taylor H; Popelka S; Moser MA; Crispell G; Wei H; Burke R; Tersch RV
    Med J (Ft Sam Houst Tex); 2021; (PB 8-21-01/02/03):83-89. PubMed ID: 33666917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An in vitro model for assessment of SARS-CoV-2 infectivity by defining the correlation between virus isolation and quantitative PCR value: isolation success of SARS-CoV-2 from oropharyngeal swabs correlates negatively with Cq value.
    Sonnleitner ST; Dorighi J; Jansen B; Schönegger C; Gietl S; Koblmüller S; Sturmbauer C; Posch W; Walder G
    Virol J; 2021 Apr; 18(1):71. PubMed ID: 33827618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding, Verifying, and Implementing Emergency Use Authorization Molecular Diagnostics for the Detection of SARS-CoV-2 RNA.
    Mitchell SL; St George K; Rhoads DD; Butler-Wu SM; Dharmarha V; McNult P; Miller MB
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32381642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carrying out pseudo dual nucleic acid detection from sample to visual result in a polypropylene bag with CRISPR/Cas12a.
    Wu H; Chen Y; Shi Y; Wang L; Zhang M; Wu J; Chen H
    Biosens Bioelectron; 2021 Apr; 178():113001. PubMed ID: 33493900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mass testing after a single suspected or confirmed case of COVID-19 in London care homes, April-May 2020: implications for policy and practice.
    Tang S; Sanchez Perez M; Saavedra-Campos M; Paranthaman K; Myers R; Fok J; Crawley-Boevey E; Dun-Campbell K; Janarthanan R; Fernandez E; Vusirikala A; Patel B; Ma T; Amin-Chowdhury Z; Shetty N; Zambon M; Bell A; Wynne-Evans E; Chow Y; Ladhani S
    Age Ageing; 2021 May; 50(3):649-656. PubMed ID: 33620453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the Roche cobas 6800 SARS-CoV-2 test and the Taiwan CDC protocol for the molecular diagnosis of COVID-19.
    You HL; Lin MC; Lee CH
    Biomed J; 2021 Mar; 44(1):101-104. PubMed ID: 33736952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro diagnostics of coronavirus disease 2019: Technologies and application.
    Lai CC; Wang CY; Ko WC; Hsueh PR
    J Microbiol Immunol Infect; 2021 Apr; 54(2):164-174. PubMed ID: 32513617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of three polymerase chain reaction-based assays for detection of SARS-CoV-2 in different upper respiratory tract specimens.
    Eberly AR; Germer JJ; Boerger AC; Fernholz EC; Binnicker MJ; Yao JD
    Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115441. PubMed ID: 34186320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overcoming limitations in the availability of swabs systems used for SARS-CoV-2 laboratory diagnostics.
    Nairz M; Bellmann-Weiler R; Ladstätter M; Schüllner F; Zimmermann M; Koller AM; Blunder S; Naschberger H; Klotz W; Herold M; Kerndler S; Jeske M; Haschka D; Petzer V; Schroll A; Sonnweber T; Tancevski I; Fritsche G; de Araujo MEG; Stasyk T; Huber LA; Griesmacher A; Theurl I; Weiss G
    Sci Rep; 2021 Jan; 11(1):2261. PubMed ID: 33500503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Highly Automated Mobile Laboratory for On-site Molecular Diagnostics in the COVID-19 Pandemic.
    Xing W; Wang J; Zhao C; Wang H; Bai L; Pan L; Li H; Wang H; Zhang Z; Lu Y; Chen X; Shan S; Wang D; Pan Y; Weng D; Zhou X; Huang R; He J; Jin R; Li W; Shang H; Zhong N; Cheng J
    Clin Chem; 2021 Mar; 67(4):672-683. PubMed ID: 33788940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding the Barriers to Pooled SARS-CoV-2 Testing in the United States.
    Fenichel EP; Koch RT; Gilbert A; Gonsalves G; Wyllie AL
    Microbiol Spectr; 2021 Sep; 9(1):e0031221. PubMed ID: 34378949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of a modified CDC assay and performance comparison with the NeuMoDx™ and DiaSorin® automated assays for rapid detection of SARS-CoV-2 in respiratory specimens.
    Lima A; Healer V; Vendrone E; Silbert S
    J Clin Virol; 2020 Dec; 133():104688. PubMed ID: 33220549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical evaluation of a multiplex real-time RT-PCR assay for detection of SARS-CoV-2 in individual and pooled upper respiratory tract samples.
    Laverack M; Tallmadge RL; Venugopalan R; Cronk B; Zhang X; Rauh R; Saunders A; Nelson WM; Plocharczyk E; Diel DG
    Arch Virol; 2021 Sep; 166(9):2551-2561. PubMed ID: 34259914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of False-Positive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Molecular Results in a High-Throughput Open-Platform System.
    Martinez RJ; Pankratz N; Schomaker M; Daniel J; Beckman K; Karger AB; Thyagarajan B; Ferreri P; Yohe SL; Nelson AC
    J Mol Diagn; 2021 Sep; 23(9):1085-1096. PubMed ID: 34116245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.